The inhibitory activity of KB-5246 against Escherichia coi DNA gyrase and the antibacterial activity and apparent uptake in E. coil and Salmonella typhimurium outer membrane mutants of KB-5246 were measured.
KB-5246 is a new quinolone which has a tetracyclic structure (10) . The antibacterial activities of the quinolones have been explained by the inhibition of DNA gyrase activity and the level of uptake (1-4, 6-9, 11, 12) . It was reported that the quinolones were taken up by simple diffusion through a porin(s) or nonporin pathway on the outer membrane (2, 3). Hirai et al. (7) reported that norfloxacin diffuses mainly through an OmpF porin and that nalidixic acid permeates through both OmpF and lipid bilayers. In this study, we measured the inhibitory activity of KB-5246 against Escherichia coli DNA gyrase as well as the antibacterial activity and apparent uptake of KB-5246 in E. coli and Salmonella typhimurium outer membrane mutants to elucidate its potent antibacterial activity.
MATERIALS AND METHODS
Bacterial strains. The E. coli strains used in this study were all derivatives of E. coli K-12. E. coli MC4100 (FlacUJ69 araD139 rpsL relA thiA fibB), MH1160 (MC4100 ompRI), MH760 (MC4100 ompR2), and MH1461 (MC4100 envZII) were kindly donated by S. Mizushima, and E. coli KEA13 (KL-16 norB) was kindly donated by K. Hirai bilities. Antibiotic medium 3 (Difco Laboratories) was used to measure the apparent uptake.
Determination of susceptibility. MICs were determined by the agar dilution method. An overnight culture of the bacterial strain in Sensitivity Test Broth was diluted 100-fold with buffered saline gelatin, and 5 ,ul of the bacterial suspension (about S x 106 cells per ml) was inoculated with an inoculator onto Sensitivity Disk Agar plates containing serial twofold dilutions of the agents. MICs were determined after 18 h of incubation at 37°C.
Inhibitory effect on E. coli DNA gyrase. The inhibitory effect of KB-5246 on E. coli KL-16 DNA gyrase was measured by the method of Fujimaki et al. (5) .
Uptake of KB-5246 in outer membrane mutants of E. coli and S. typhimurium. The apparent uptake of KB-5246 and norfloxacin was measured by a modification of the method of Hirai et al. (7, 8) . Bacterial cells were grown to an optical density at 600 nm of 0.7. The concentrations of cells at this optical density were 0.2 x 108 to 1.0 x 108 CFU/ml. KB-5246 or norfloxacin was added to the bacterial suspensions to a concentration of 10 ,ug/ml, and the suspensions were incubated for 10 min at 37°C. After the suspensions were washed with 2 ml of saline by centrifugation, the obtained prepicitate was suspended in 5% acetic acid. The suspension was immersed in boiling water for 5 min and centrifuged. The amount of KB-5246 or norfloxacin in the resulting supernatant was defined as the apparent uptake. The concentration in the supernatant was determined by high-pressure liquid chromatography with a YMC A-312 column (Yamamura Kagaku Co. Ltd.), a mobile phase of 5% acetic acid-methanol (85:15), a flow rate of 1.5 ml/min, and detec- Tables 2 and 3 . The ratios of the MIC against the mutant to that against the parent were readily reproducible. The activity of norfloxacin was fourfold lower against E. coli MH1461 but comparable against E. coli MH760 when compared with that against the parent strain MC4100. The activity of nalidixic acid against these strains was similar to that against the parent. KB-5246 had twofold-lower activity against MH1461 and twofoldhigher activity against MH760 than against the parent. Although the activities of nalidixic acid and chloramphenicol were the same against MH1461 as against the parent, they were twofold lower against E. coli KEA13 than against the parent strain KL-16.
In good accordance with the results of a previous report (6) , the MICs of norfloxacin against rough mutants were not altered, and the MIC of nalidixic acid against the deep rough mutant was eightfold higher than that against the parent. KB-5246 had twofold-higher activity against the deep rough mutant than against the parent.
KB-5246 had more hydrophobic characteristics than had the other quinolones tested (Tables 2 and 3 ).
The apparent uptake of KB-5246 in E. coli and S. typhimurium outer membrane mutants was measured and compared with that of norfloxacin (Fig. 1) . The uptake of norfloxacin in the OmpF-deficient mutant was decreased and its uptake in the deep rough mutant was not altered when compared with those of the parents. Like the uptake of norfloxacin, the uptake of KB-5246 in the OmpF-deficient mutant was decreased when compared with that in the parent. However, the uptake of KB-5246 in the deep rough mutant was increased when compared with that in the parent. Although the apparent uptake of KB-5246 was 10-fold higher than that of norfloxacin in E. coli MC4100, the high level of apparent uptake of KB-5246 was not reflected in antibacterial activity. DISCUSSION KB-5246 had potent activity against both gram-positive and gram-negative bacteria (8) . To elucidate the potent activity, we measured the inhibitory activity of KB-5246 against E. coli KL-16 DNA gyrase and the apparent uptake in E. coli and S. typhimurium outer membrane mutants. KB-5246 had potent inhibitory activity against DNA gyrase. In accordance with antibacterial activity and hydrophobicity, the apparent uptake of KB-5246 in the OmpF-deficient mutant was decreased and its uptake in the deep rough mutant was increased when compared with those in the parents. In our preliminary study, KB-5246 induced cell lysis by sodium dodecyl sulfate, as reported for fleroxacin (3). These results suggest that KB-5246 was taken up by both porin and nonporin pathways.
The potent antibacterial activity of KB-5246 might be explained by the following two factors: a strong inhibitory activity against DNA gyrase and the uptake of KB-5246 by both porin and nonporin pathways. Although nalidixic acid and chloramphenicol had twofold-lower activities against E. coli KEA13, their activities were not altered by the envZJJ mutation. These results suggest that the decrease in the antibacterial activities of nalidixic acid and chloramphenicol was not caused by a deficiency in the porin but by another factor, probably an alteration of lipopolysaccharide. KB-5246 showed about 10-fold-higher uptake than norfloxacin. However, the difference in the apparent uptake levels between KB-5246 and norfloxacin did not reflect their antibacterial activities. This phenomenon suggests that not all of the agent which interacts with the cell wall passes through the bacterial inner membrane and thus can not interact with the target enzyme, DNA gyrase. KB-5246 was much more hydrophobic than were norfloxacin and nalidixic acid. A large number of KB-5246 molecules may be sequestered in the lipid bilayer.
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